As the applications of metabolic imaging are expanding, radiolabeled amino
acids may gain increased clinical interest, This review first describes the
basic aspects of amino acid metabolism, then continues with basic aspects
of radiolabeled amino acids, and finally describes clinical applications, w
ith an emphasis on diagnostic value. A special focus is on C-11-methionine,
C-11-tyrosine, and I-123-iodomethyltyrosine, because these have been most
used clinically, although their common affinity for the L-transport systems
may limit generalization to other classes of amino acids. The theoretic an
d preclinical background of amino acid imaging is sound and supports clinic
al applications. The fact that amino acid imaging is less influenced by inf
lammation may be advantageous in comparison with F-18-FDG PET imaging, alth
ough tumor specificity is not absolute. In brain tumor imaging, the use of
radiolabeled amino acids is established, the diagnostic accuracy of amino a
cid imaging seems adequate, and the diagnostic value seems advantageous. Th
e general feasibility of amino acid imaging in other tumor types has suffic
iently been shown, but more research is required in larger patient series a
nd in well-defined clinical settings.